Hemang Kamlesh Vohra

Hemang Kamlesh Vohra

Active Director Director DIN 06363338
DIN 06363338 First appointment Aug 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Aug 2012
Shareholding value •••• Premium profile

About Hemang Kamlesh Vohra

Data last updated:

Hemang Kamlesh Vohra is a Director at Galentic Pharma India Pvt Ltd (since 2013) and Director at Apollo Business Technologies Private Limited (since 2012). The companies operate in Pharma, Business Outsourcing and Education & Learing. The 2 current companies with reported revenue have a combined latest revenue of ₹195 Cr; the largest is Galentic Pharma India Pvt Ltd at ₹195 Cr (FY 2025). Earlier, Hemang Kamlesh Vohra was a Director at Trivas Education Private Limited (2013–2018) and Additional Director at Chemvalve Industries Private Limited (from 2023).

DIN 06363338
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2012
Oldest Company Age 54 yrs
Largest company Galentic Pharma India Pvt Ltd · ₹195 Cr (FY 2025)
Combined revenue ₹195 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Galentic Pharma India Pvt Ltd U24230MH1992PTC065825
Director18 Mar 20131992₹195 Cr (FY 2025)Active
Director01 Aug 20122005₹14.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trivas Education Private Limited U74900MH2013PTC239509
Director10 Jan 20132013₹18,000 (FY 2017)Active
Chemvalve Industries Private Limited U29299MH1972PTC015578
Additional Director24 May 20231972₹42.9 Lakh (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Galentic Pharma India Pvt Ltd
Apollo Business Technologies Private Limited
Chemvalve Industries Private Limited
Trivas Education Private Limited
Premium access

Shareholding and investment profile for Hemang Kamlesh Vohra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemang Kamlesh Vohra

Hemang Kamlesh Vohra currently holds 2 directorships: Galentic Pharma India Pvt Ltd (Director, since 18 Mar 2013, revenue ₹195 Cr (FY 2025)); Apollo Business Technologies Private Limited (Director, since 01 Aug 2012, revenue ₹14.9 Lakh (FY 2025)).

Hemang Kamlesh Vohra was first appointed on 01 Aug 2012 as Director at Apollo Business Technologies Private Limited. The most recent appointment on record is 24 May 2023 at Chemvalve Industries Private Limited.

The 2 current companies of Hemang Kamlesh Vohra that report revenue have a combined latest revenue of ₹195 Cr: Galentic Pharma India Pvt Ltd ₹195 Cr (FY 2025); Apollo Business Technologies Private Limited ₹14.9 Lakh (FY 2025).

Hemang Kamlesh Vohra held 2 earlier board appointments: Trivas Education Private Limited (Director, 10 Jan 2013 to 13 Mar 2018); Chemvalve Industries Private Limited (Additional Director, from 24 May 2023).

The current boards of Hemang Kamlesh Vohra's companies include Amisha Maulin Gandhi (Galentic Pharma India Pvt Ltd), Bhupendra Harkisandas Sangani (Galentic Pharma India Pvt Ltd), Jay Narendra Mehta (Galentic Pharma India Pvt Ltd), Kamlesh Satyendra Vohra (Galentic Pharma India Pvt Ltd), Manthan Kamlesh Vohra (Galentic Pharma India Pvt Ltd), Smita Bhupendra Sangani (Galentic Pharma India Pvt Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available